H.C. Wainwright Keeps Buy on Madrigal Pharmaceuticals (MDGL) on Strong Rezdiffra Uptake and F2/F3 MASH Patient Data

11 12 月, 2025

One Min Read

6 Views

原文: https://finance.yahoo.com/news/h-c-wainwright-keeps-buy-124429500.html

Last Update: 11 12 月, 2025

Written By

Other Articles

Previous

BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street

Next

Baird Lifts Mirum Pharmaceuticals, Inc. (MIRM) Price Target on Bluejay Therapeutics Acquisition

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept